<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">

<channel>
	<title>EPR Biotech News</title>
	
	<link>http://www.eprbiotechnews.com</link>
	<description />
	<pubDate>Thu, 26 Jan 2012 05:28:19 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.1</generator>
	<language>en</language>
			<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/EprBiotechNews" /><feedburner:info xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" uri="eprbiotechnews" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item>
		<title>Advinus, SignalChem Start The Multi-Year, Multi-Target Collaboration On New Anti-Cancer Drugs</title>
		<link>http://www.eprbiotechnews.com/2012/01/25/advinus-signalchem-start-the-multi-year-multi-target-collaboration-on-new-anti-cancer-drugs/</link>
		<comments>http://www.eprbiotechnews.com/2012/01/25/advinus-signalchem-start-the-multi-year-multi-target-collaboration-on-new-anti-cancer-drugs/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 05:28:19 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biomedical Engineering]]></category>

		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotech Products]]></category>

		<category><![CDATA[Biotech Services]]></category>

		<category><![CDATA[Biotech Solutions]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Genetics]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[advinus]]></category>

		<category><![CDATA[canada]]></category>

		<category><![CDATA[drug development]]></category>

		<category><![CDATA[drug discovery]]></category>

		<category><![CDATA[india]]></category>

		<category><![CDATA[investment]]></category>

		<category><![CDATA[kinase]]></category>

		<category><![CDATA[licensing]]></category>

		<category><![CDATA[oncology]]></category>

		<category><![CDATA[signalchem]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=120</guid>
		<description><![CDATA[
Advinus Therapeutics, a research-based pharmaceutical development company promoted by the TATA Group, and SignalChem Pharmaceuticals, a British Columbia-based drug discovery company, have started working on 15 programs based on SignalChem’s proprietary Kinase platform for targeted therapies in oncology. Each program is being developed with corresponding diagnostics and tracers for patient selection and biomarkers for follow [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2012/01/25/advinus-signalchem-start-the-multi-year-multi-target-collaboration-on-new-anti-cancer-drugs/feed/</wfw:commentRss>
		</item>
		<item>
		<title>CYTOO Raises 10 M$ (7M€) in Series C Round</title>
		<link>http://www.eprbiotechnews.com/2011/11/24/cytoo-raises-10-m-7me-in-series-c-round/</link>
		<comments>http://www.eprbiotechnews.com/2011/11/24/cytoo-raises-10-m-7me-in-series-c-round/#comments</comments>
		<pubDate>Thu, 24 Nov 2011 16:54:56 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biomedical Engineering]]></category>

		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotech Products]]></category>

		<category><![CDATA[Biotech Services]]></category>

		<category><![CDATA[Biotech Solutions]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Genetics]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[cell-based assays]]></category>

		<category><![CDATA[CYTOO]]></category>

		<category><![CDATA[normalized cell morphology]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=118</guid>
		<description><![CDATA[CYTOO SA, a company that specializes in cell-based assays, is pleased to announce the closing of a series C funding round of USD 10M (EUR 7M). New investors, Sham and Entrepreneurs Fund (EF), led the round. Existing investors AURIGA Partners and Jacques Lewiner, co-founder and president of the supervisory board at CYTOO, also participated.

CYTOO will [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2011/11/24/cytoo-raises-10-m-7me-in-series-c-round/feed/</wfw:commentRss>
		</item>
		<item>
		<title>GenQual Announces Initial Closing Of Its First Preferred Equity Funding Round</title>
		<link>http://www.eprbiotechnews.com/2011/11/22/genqual-announces-initial-closing-of-its-first-preferred-equity-funding-round/</link>
		<comments>http://www.eprbiotechnews.com/2011/11/22/genqual-announces-initial-closing-of-its-first-preferred-equity-funding-round/#comments</comments>
		<pubDate>Tue, 22 Nov 2011 19:43:34 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biomedical Engineering]]></category>

		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Healthcare]]></category>

		<category><![CDATA[Medicine]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[arthritis]]></category>

		<category><![CDATA[autoimmune]]></category>

		<category><![CDATA[cancer]]></category>

		<category><![CDATA[diagnostics]]></category>

		<category><![CDATA[IL-6]]></category>

		<category><![CDATA[IVD]]></category>

		<category><![CDATA[oncology]]></category>

		<category><![CDATA[personalized medicine]]></category>

		<category><![CDATA[Seattle]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=116</guid>
		<description><![CDATA[GenQual is pleased to announce initial closing of its first preferred equity round. Financial terms were not disclosed. This inaugural funding round allows GenQual to pursue proof-of-principle testing for its companion diagnostic approach for IL-6 mAb and other JAK/STAT inhibitors for autoimmune diseases and oncology indications. GenQual aims to prospectively identify responders for clinical-stage therapeutics [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2011/11/22/genqual-announces-initial-closing-of-its-first-preferred-equity-funding-round/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Michigan Institute of Urology, P. C. to Perform Clinical Trial Using Cellay, Inc’s Same Day OligoFISH® Probes for Prostate Cancer</title>
		<link>http://www.eprbiotechnews.com/2011/11/10/michigan-institute-of-urology-p-c-to-perform-clinical-trial-using-cellay-inc%e2%80%99s-same-day-oligofish%c2%ae-probes-for-prostate-cancer/</link>
		<comments>http://www.eprbiotechnews.com/2011/11/10/michigan-institute-of-urology-p-c-to-perform-clinical-trial-using-cellay-inc%e2%80%99s-same-day-oligofish%c2%ae-probes-for-prostate-cancer/#comments</comments>
		<pubDate>Thu, 10 Nov 2011 08:27:36 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotech Services]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[DNA]]></category>

		<category><![CDATA[Genetics]]></category>

		<category><![CDATA[Genome]]></category>

		<category><![CDATA[Medicine]]></category>

		<category><![CDATA[Microarrays]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[RNA]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[clinical trial for prostate cancer]]></category>

		<category><![CDATA[Urology]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=114</guid>
		<description><![CDATA[St. Clair Shores, Michigan and Cambridge, Massachusetts – Michigan Institute of Urology, P. C. (MIU) and Cellay, Inc. today announced that MIU will exclusively perform a clinical trial for prostate cancer using Cellay&#8217;s Same Day OligoFISH® probe panel. Data from this trial will be included in Cellay&#8217;s premarket approval (PMA) application for submission to the [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2011/11/10/michigan-institute-of-urology-p-c-to-perform-clinical-trial-using-cellay-inc%e2%80%99s-same-day-oligofish%c2%ae-probes-for-prostate-cancer/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Advanced Liquid Logic Licenses Patents, Creates Collaboration With CEA-Leti</title>
		<link>http://www.eprbiotechnews.com/2011/09/27/advanced-liquid-logic-licenses-patents-creates-collaboration-with-cea-leti/</link>
		<comments>http://www.eprbiotechnews.com/2011/09/27/advanced-liquid-logic-licenses-patents-creates-collaboration-with-cea-leti/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 22:38:45 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biochemicals]]></category>

		<category><![CDATA[Biomedical Engineering]]></category>

		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotech Solutions]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Healthcare]]></category>

		<category><![CDATA[Licenses]]></category>

		<category><![CDATA[Medical Technologies]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[Advanced Liquid Logic]]></category>

		<category><![CDATA[CEA]]></category>

		<category><![CDATA[Digital Microfluidics]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=112</guid>
		<description><![CDATA[

Advanced Liquid Logic announced today that it has signed a license and collaboration agreement with the French research institute CEA-Leti. The agreement provides Advanced Liquid Logic with worldwide exclusive access to CEA’s portfolio of patents related to digital microfluidics.
Advanced Liquid Logic co-founder and Dr. Michael Pollack said, “This agreement puts our company in a clearly [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2011/09/27/advanced-liquid-logic-licenses-patents-creates-collaboration-with-cea-leti/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Enabling microRNA Discoveries - 250th Peer-Reviewed Publication Made Possible By µparaflo Custom Microarray Technology</title>
		<link>http://www.eprbiotechnews.com/2011/06/09/enabling-microrna-discoveries-250th-peer-reviewed-publication-made-possible-by-%c2%b5paraflo-custom-microarray-technology/</link>
		<comments>http://www.eprbiotechnews.com/2011/06/09/enabling-microrna-discoveries-250th-peer-reviewed-publication-made-possible-by-%c2%b5paraflo-custom-microarray-technology/#comments</comments>
		<pubDate>Thu, 09 Jun 2011 22:54:22 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotech Services]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[DNA]]></category>

		<category><![CDATA[Genome]]></category>

		<category><![CDATA[Microarrays]]></category>

		<category><![CDATA[Proteomics]]></category>

		<category><![CDATA[RNA]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[Vaccines]]></category>

		<category><![CDATA[expression profiling]]></category>

		<category><![CDATA[gene expression]]></category>

		<category><![CDATA[microrarray]]></category>

		<category><![CDATA[microRNA]]></category>

		<category><![CDATA[miRNA]]></category>

		<category><![CDATA[rna-seq]]></category>

		<category><![CDATA[uparaflo]]></category>

		<category><![CDATA[wolbachia]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=110</guid>
		<description><![CDATA[

LC Sciences, a life sciences company leading the development of innovative microRNA (miRNA) analysis and discovery technologies, announced today the publication of over 250 peer-reviewed studies using the company’s microarray service for analyzing miRNA expression profiles. These studies, by leading researchers in the field, represent significant steps toward realizing these small regulatory RNA’s potential as biomarkers [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2011/06/09/enabling-microrna-discoveries-250th-peer-reviewed-publication-made-possible-by-%c2%b5paraflo-custom-microarray-technology/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Investor Stem Cell Launches Online Discussion Community Dedicated To Stem Cell Investors: (OTC-ACTC) (NASDAQ-GERN) (AMEX-BTX) (NASDAQ:ATHX)</title>
		<link>http://www.eprbiotechnews.com/2011/04/29/investor-stem-cell-launches-online-discussion-community-dedicated-to-stem-cell-investors-otc-actc-nasdaq-gern-amex-btx-nasdaqathx/</link>
		<comments>http://www.eprbiotechnews.com/2011/04/29/investor-stem-cell-launches-online-discussion-community-dedicated-to-stem-cell-investors-otc-actc-nasdaq-gern-amex-btx-nasdaqathx/#comments</comments>
		<pubDate>Fri, 29 Apr 2011 19:53:04 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biochemicals]]></category>

		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotech Products]]></category>

		<category><![CDATA[Biotech Services]]></category>

		<category><![CDATA[Biotech Solutions]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Healthcare]]></category>

		<category><![CDATA[Medicine]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[ACTC]]></category>

		<category><![CDATA[Advanced Cell Technology]]></category>

		<category><![CDATA[ASTM]]></category>

		<category><![CDATA[Biotime]]></category>

		<category><![CDATA[BTX]]></category>

		<category><![CDATA[CBAI]]></category>

		<category><![CDATA[Geron]]></category>

		<category><![CDATA[OTC:ACTC]]></category>

		<category><![CDATA[PSTI]]></category>

		<category><![CDATA[STEM]]></category>

		<category><![CDATA[Stem cells]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=108</guid>
		<description><![CDATA[Investor Stem Cell (http://www.investorstemcell.com) is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible medical advancements taking place in the regenerative medicine sector. Scientists are using stem cells both (hESC) and (iPSC) in hopes of easing the suffering of hundreds of millions of people world wide.

Our society is on [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2011/04/29/investor-stem-cell-launches-online-discussion-community-dedicated-to-stem-cell-investors-otc-actc-nasdaq-gern-amex-btx-nasdaqathx/feed/</wfw:commentRss>
		</item>
		<item>
		<title>MicroTissues, Inc. Announces New Product Launch for the 3D Petri Dish™</title>
		<link>http://www.eprbiotechnews.com/2011/03/23/microtissues-inc-announces-new-product-launch-for-the-3d-petri-dish%e2%84%a2/</link>
		<comments>http://www.eprbiotechnews.com/2011/03/23/microtissues-inc-announces-new-product-launch-for-the-3d-petri-dish%e2%84%a2/#comments</comments>
		<pubDate>Wed, 23 Mar 2011 18:02:14 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biochemicals]]></category>

		<category><![CDATA[Biomedical Engineering]]></category>

		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Healthcare]]></category>

		<category><![CDATA[Microarrays]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[3d cell culture]]></category>

		<category><![CDATA[cell culture]]></category>

		<category><![CDATA[mammospheres]]></category>

		<category><![CDATA[neurospheres]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=106</guid>
		<description><![CDATA[MicroTissues, Inc. announced today the launch of its 3D Petri Dish™ line of products. The 3D Petri Dish™ is a new tool for the world wide industry of life sciences research and drug discovery. Invented at Brown University, the 3D Petri Dish™ grows living human cells in three dimensions (3D) where they replicate the function [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2011/03/23/microtissues-inc-announces-new-product-launch-for-the-3d-petri-dish%e2%84%a2/feed/</wfw:commentRss>
		</item>
		<item>
		<title>MicroTissues, Inc.’s 3D Petri Dish™ Is Helping to Reduce Animal Use in Research</title>
		<link>http://www.eprbiotechnews.com/2011/03/09/microtissues-incs-3d-petri-dish%e2%84%a2-is-helping-to-reduce-animal-use-in-research/</link>
		<comments>http://www.eprbiotechnews.com/2011/03/09/microtissues-incs-3d-petri-dish%e2%84%a2-is-helping-to-reduce-animal-use-in-research/#comments</comments>
		<pubDate>Wed, 09 Mar 2011 12:49:11 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biochemicals]]></category>

		<category><![CDATA[Biomedical Engineering]]></category>

		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Healthcare]]></category>

		<category><![CDATA[Microarrays]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[Tissue Engineering]]></category>

		<category><![CDATA[3d cell culture]]></category>

		<category><![CDATA[drug discovery]]></category>

		<category><![CDATA[mammospheres]]></category>

		<category><![CDATA[neuropsheres]]></category>

		<category><![CDATA[regenerative medicine]]></category>

		<category><![CDATA[tissues engineering]]></category>

		<category><![CDATA[toxicity testing]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=104</guid>
		<description><![CDATA[MicroTissues, Inc. announced today that its 3D Petri Dish™ is targeted towards helping to reduce the numbers of animals used in research. The 3D Petri Dish™ is a new tool for the world wide industry of life sciences research and drug discovery that grows living cells in three dimensions (3D). These 3D microtissues replicate the function [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2011/03/09/microtissues-incs-3d-petri-dish%e2%84%a2-is-helping-to-reduce-animal-use-in-research/feed/</wfw:commentRss>
		</item>
		<item>
		<title>MicroTissues, Inc.’s 3D Petri Dish™ Used in Time Magazine’s Medical Breakthrough of 2010</title>
		<link>http://www.eprbiotechnews.com/2011/03/01/microtissues-incs-3d-petri-dish%e2%84%a2-used-in-time-magazines-medical-breakthrough-of-2010/</link>
		<comments>http://www.eprbiotechnews.com/2011/03/01/microtissues-incs-3d-petri-dish%e2%84%a2-used-in-time-magazines-medical-breakthrough-of-2010/#comments</comments>
		<pubDate>Tue, 01 Mar 2011 18:06:23 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biochemicals]]></category>

		<category><![CDATA[Biomedical Engineering]]></category>

		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Healthcare]]></category>

		<category><![CDATA[Microarrays]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[Tissue Engineering]]></category>

		<category><![CDATA[3 d cell culture]]></category>

		<category><![CDATA[3d cell culture]]></category>

		<category><![CDATA[3d petri dish]]></category>

		<category><![CDATA[cell culture]]></category>

		<category><![CDATA[mammospheres]]></category>

		<category><![CDATA[micro tissues]]></category>

		<category><![CDATA[microtissues]]></category>

		<category><![CDATA[neuropsheres]]></category>

		<category><![CDATA[petri dish]]></category>

		<category><![CDATA[petri dishes]]></category>

		<category><![CDATA[spheroids]]></category>

		<category><![CDATA[three dimensional cell culture]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=102</guid>
		<description><![CDATA[MicroTissues, Inc. announced today that its 3D Petri Dish™ was used in one of Time magazine’s medical breakthroughs of 2010. Researchers at Brown University and Women and Infants Hospital used the 3D Petri Dish™ to invent the first artificial human ovary, a discovery important for fertility research and a possible infertility treatment for cancer patients. In [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2011/03/01/microtissues-incs-3d-petri-dish%e2%84%a2-used-in-time-magazines-medical-breakthrough-of-2010/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Assay-Ready Chemistry Partnership between Enamine and Molplex</title>
		<link>http://www.eprbiotechnews.com/2011/01/24/assay-ready-chemistry-partnership-between-enamine-and-molplex/</link>
		<comments>http://www.eprbiotechnews.com/2011/01/24/assay-ready-chemistry-partnership-between-enamine-and-molplex/#comments</comments>
		<pubDate>Mon, 24 Jan 2011 21:42:39 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotech Services]]></category>

		<category><![CDATA[Biotech Solutions]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Healthcare]]></category>

		<category><![CDATA[Online]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[Enamine]]></category>

		<category><![CDATA[Molplex]]></category>

		<category><![CDATA[online drug design]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=98</guid>
		<description><![CDATA[
Molplex and Enamine today announced a new partnership to offer the Enamine screening collection of 1.8 million stock chemicals through the Molplex online drug design and assay-ready chemical supply services. The agreement is a major step towards eliminating the high start-up costs ofdrug discovery, bringing sophisticated drug design, compound management and assay-ready chemistry to the world&#8217;s drug discovery scientists [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2011/01/24/assay-ready-chemistry-partnership-between-enamine-and-molplex/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Gene Therapy and Stem Cell Therapy Standard Developed For A Unique Derivative Of Post Hetero-Plastic Inplantation Chronic Inflammation Syndrome, The NIDO Disease</title>
		<link>http://www.eprbiotechnews.com/2011/01/24/gene-therapy-and-stem-cell-therapy-standard-developed-for-a-unique-derivative-of-post-hetero-plastic-inplantation-chronic-inflammation-syndrome-the-nido-disease/</link>
		<comments>http://www.eprbiotechnews.com/2011/01/24/gene-therapy-and-stem-cell-therapy-standard-developed-for-a-unique-derivative-of-post-hetero-plastic-inplantation-chronic-inflammation-syndrome-the-nido-disease/#comments</comments>
		<pubDate>Mon, 24 Jan 2011 21:34:16 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biochemicals]]></category>

		<category><![CDATA[Biomedical Engineering]]></category>

		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotech Products]]></category>

		<category><![CDATA[Biotech Services]]></category>

		<category><![CDATA[Biotech Solutions]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[DNA]]></category>

		<category><![CDATA[Gene]]></category>

		<category><![CDATA[Genome]]></category>

		<category><![CDATA[Healthcare]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[cancer]]></category>

		<category><![CDATA[chronic inflammation]]></category>

		<category><![CDATA[DSM-TM]]></category>

		<category><![CDATA[Gene Therapy]]></category>

		<category><![CDATA[lymphoma]]></category>

		<category><![CDATA[MIT Standaard Manual]]></category>

		<category><![CDATA[post hetero-plastic implantation chronic inflammation syndrome]]></category>

		<category><![CDATA[stem cell therapy]]></category>

		<category><![CDATA[tumor]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=96</guid>
		<description><![CDATA[Researchers task force, led by faculties of T-Protocol, registered Genom Project as controlled genom project in the hosted database of NCBI, a publication matter authority and function assigned organization under oversee of Department of Health &#38; Human Services, reached once to share the exegetical impression officially pre-published concerning the understanding specific spectrum of symptoms covering [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2011/01/24/gene-therapy-and-stem-cell-therapy-standard-developed-for-a-unique-derivative-of-post-hetero-plastic-inplantation-chronic-inflammation-syndrome-the-nido-disease/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Nationaly Registered T-Protocol Of Genom Project Successfully Applied To Retrieve Bio Mechanism Of Hair Regrowth</title>
		<link>http://www.eprbiotechnews.com/2011/01/13/nationaly-registered-t-protocol-of-genom-project-successfully-applied-to-retrieve-bio-mechanism-of-hair-regrowth/</link>
		<comments>http://www.eprbiotechnews.com/2011/01/13/nationaly-registered-t-protocol-of-genom-project-successfully-applied-to-retrieve-bio-mechanism-of-hair-regrowth/#comments</comments>
		<pubDate>Thu, 13 Jan 2011 12:35:08 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biochemicals]]></category>

		<category><![CDATA[Biomedical Engineering]]></category>

		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotech Products]]></category>

		<category><![CDATA[Biotech Services]]></category>

		<category><![CDATA[Biotech Solutions]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[DNA]]></category>

		<category><![CDATA[Gene]]></category>

		<category><![CDATA[Genome]]></category>

		<category><![CDATA[Healthcare]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[A20]]></category>

		<category><![CDATA[chronic inflammation]]></category>

		<category><![CDATA[Gene Theraphy for Huntington's disease]]></category>

		<category><![CDATA[hair follicles]]></category>

		<category><![CDATA[Huntington's disease]]></category>

		<category><![CDATA[NIDO disease]]></category>

		<category><![CDATA[NIDO syndrome]]></category>

		<category><![CDATA[polyglutamine]]></category>

		<category><![CDATA[stem cell for AGA]]></category>

		<category><![CDATA[stem cell for baldness]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=94</guid>
		<description><![CDATA[Division of Gene Medicine &#38; Stem Cell Application, School of Medical Science, complete the research and established completely new protocol totally recovering natural bio mechanism of hair regrowth.

The researchers, led by Lord. Prof. Dr. Daichent Otto Rie, specified protein and genom to affect internal bio mechanism to generate hair and control the level of successful growth [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2011/01/13/nationaly-registered-t-protocol-of-genom-project-successfully-applied-to-retrieve-bio-mechanism-of-hair-regrowth/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Drug Discovery On Demand By Molplex</title>
		<link>http://www.eprbiotechnews.com/2010/11/05/drug-discovery-on-demand-by-molplex/</link>
		<comments>http://www.eprbiotechnews.com/2010/11/05/drug-discovery-on-demand-by-molplex/#comments</comments>
		<pubDate>Fri, 05 Nov 2010 16:58:15 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotech Services]]></category>

		<category><![CDATA[Biotech Solutions]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Healthcare]]></category>

		<category><![CDATA[Online]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[3d shape match]]></category>

		<category><![CDATA[assay ready chemicals]]></category>

		<category><![CDATA[biacore]]></category>

		<category><![CDATA[chemical supply]]></category>

		<category><![CDATA[drug design]]></category>

		<category><![CDATA[drug discovery]]></category>

		<category><![CDATA[high content screening]]></category>

		<category><![CDATA[ligand docking]]></category>

		<category><![CDATA[multi-property optimization]]></category>

		<category><![CDATA[pharmacophore]]></category>

		<category><![CDATA[QSAR]]></category>

		<category><![CDATA[virtual screening]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=92</guid>
		<description><![CDATA[
An innovative new online “drug discovery on demand” platform has been launched by Molplex, a company specializing in products and services for the life sciences. Designed to help drug discovery groups working anywhere in the world, it aimsto eliminate the high start-up costs and minimize the financial risks traditionally associated with inventing new medicines.

Molplex CEO [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2010/11/05/drug-discovery-on-demand-by-molplex/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Turkey’s Biopharmaceutical Sector Attracts, Boosts Research and Development Expenditures</title>
		<link>http://www.eprbiotechnews.com/2010/09/23/turkeys-biopharmaceutical-sector-attracts-boosts-research-and-development-expenditures/</link>
		<comments>http://www.eprbiotechnews.com/2010/09/23/turkeys-biopharmaceutical-sector-attracts-boosts-research-and-development-expenditures/#comments</comments>
		<pubDate>Thu, 23 Sep 2010 12:41:01 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biochemicals]]></category>

		<category><![CDATA[Biomedical Engineering]]></category>

		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Policy]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[access to medicine]]></category>

		<category><![CDATA[R&amp;D investment]]></category>

		<category><![CDATA[Turkey]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=90</guid>
		<description><![CDATA[
A recent report on the biopharmaceutical sector presence, employment, economic output and research and development activity in the European States highlights Turkey’s long-term prospects for growth. The report notes that the industry is creating a positive ripple across the region’s economy, improving the quality of life for its citizens and increasing access to medicine.

In particular, [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2010/09/23/turkeys-biopharmaceutical-sector-attracts-boosts-research-and-development-expenditures/feed/</wfw:commentRss>
		</item>
		<item>
		<title>The Porcine microRNAome is Revealed</title>
		<link>http://www.eprbiotechnews.com/2010/08/20/the-porcine-micrornaome-is-revealed/</link>
		<comments>http://www.eprbiotechnews.com/2010/08/20/the-porcine-micrornaome-is-revealed/#comments</comments>
		<pubDate>Fri, 20 Aug 2010 20:29:07 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotech Services]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[DNA]]></category>

		<category><![CDATA[Genome]]></category>

		<category><![CDATA[Microarrays]]></category>

		<category><![CDATA[Proteomics]]></category>

		<category><![CDATA[RNA]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[Vaccines]]></category>

		<category><![CDATA[bioinformatics]]></category>

		<category><![CDATA[deep sequencing]]></category>

		<category><![CDATA[microRNA]]></category>

		<category><![CDATA[micrornaome]]></category>

		<category><![CDATA[miRNA]]></category>

		<category><![CDATA[mirnaome]]></category>

		<category><![CDATA[pig genome]]></category>

		<category><![CDATA[sus scrofa]]></category>

		<category><![CDATA[transcriptome]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=88</guid>
		<description><![CDATA[
Researchers from LC Sciences LLC and a collaboration of Universities1 have established a porcine microRNAome, a complete catalog of all microRNAs expressed in the species Sus scrofa2. MicroRNAs (miRNAs) are small regulatory RNA molecules known to control a wide array of cellular functions such as growth and development and whose dysregulation has been associated with [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2010/08/20/the-porcine-micrornaome-is-revealed/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Cryo-Cell CEO Mercedes Walton Invites Women to Share Their Ideas on Self-Care and the Power of Stem Cells</title>
		<link>http://www.eprbiotechnews.com/2010/07/10/cryo-cell-ceo-mercedes-walton-invites-women-to-share-their-ideas-on-self-care-and-the-power-of-stem-cells/</link>
		<comments>http://www.eprbiotechnews.com/2010/07/10/cryo-cell-ceo-mercedes-walton-invites-women-to-share-their-ideas-on-self-care-and-the-power-of-stem-cells/#comments</comments>
		<pubDate>Sat, 10 Jul 2010 13:54:19 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biochemicals]]></category>

		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotech Products]]></category>

		<category><![CDATA[Biotech Services]]></category>

		<category><![CDATA[Biotech Solutions]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Healthcare]]></category>

		<category><![CDATA[Medicine]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[breast cancer]]></category>

		<category><![CDATA[Cryo-Cell International]]></category>

		<category><![CDATA[Inc.]]></category>

		<category><![CDATA[menstrual blood stem cells]]></category>

		<category><![CDATA[Stem cells]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=86</guid>
		<description><![CDATA[
Cryo-Cell International, Inc. a global leader in stem cell innovation, resolves to help women inspire and empower each other to take charge of their health in the New Year, and to spark conversations about the promise of stem cells.  The company will be accepting video entries for its “Resolution Revolution” contest through January 31, 2010, [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2010/07/10/cryo-cell-ceo-mercedes-walton-invites-women-to-share-their-ideas-on-self-care-and-the-power-of-stem-cells/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Cord Blood: Saving For The Future</title>
		<link>http://www.eprbiotechnews.com/2010/07/10/cord-blood-saving-for-the-future/</link>
		<comments>http://www.eprbiotechnews.com/2010/07/10/cord-blood-saving-for-the-future/#comments</comments>
		<pubDate>Sat, 10 Jul 2010 13:52:19 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biochemicals]]></category>

		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotech Products]]></category>

		<category><![CDATA[Biotech Services]]></category>

		<category><![CDATA[Biotech Solutions]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Healthcare]]></category>

		<category><![CDATA[Medicine]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[cord blood]]></category>

		<category><![CDATA[cord blood banks]]></category>

		<category><![CDATA[cord blood stem cells]]></category>

		<category><![CDATA[Cryo-Cell International]]></category>

		<category><![CDATA[Inc.]]></category>

		<category><![CDATA[umbilical cord blood]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=84</guid>
		<description><![CDATA[
For an expectant mother, there are a million details to worry about and a lot of important decisions to be made.

One of those decisions to be made is whether to bank your baby&#8217;s umbilical cord blood. Cord blood is valuable because it&#8217;s full of stem cells scientists and doctors can use in research and regenerative medicine.
&#8220;Cord [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2010/07/10/cord-blood-saving-for-the-future/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Scientist Uses Stem Cells To Repair Heart</title>
		<link>http://www.eprbiotechnews.com/2010/07/10/scientist-uses-stem-cells-to-repair-heart/</link>
		<comments>http://www.eprbiotechnews.com/2010/07/10/scientist-uses-stem-cells-to-repair-heart/#comments</comments>
		<pubDate>Sat, 10 Jul 2010 13:50:42 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biochemicals]]></category>

		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotech Products]]></category>

		<category><![CDATA[Biotech Services]]></category>

		<category><![CDATA[Biotech Solutions]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Healthcare]]></category>

		<category><![CDATA[Medicine]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[cord blood stem cells]]></category>

		<category><![CDATA[Cryo-Cell International]]></category>

		<category><![CDATA[embryonic stem cells]]></category>

		<category><![CDATA[Inc.]]></category>

		<category><![CDATA[stem cell cord blood collections]]></category>

		<category><![CDATA[Stem cells]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=82</guid>
		<description><![CDATA[
Dr. Joshua Hare believes medicine is close to a goal long thought to be impossible: healing the human heart.
The way to get there? Stem cells.

&#8220;These could be as big as antibiotics were in the last century,&#8221; said Hare, who leads the University of Miami &#8217;s new Stem Cell Institute. &#8220;Stem cells have the potential to [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2010/07/10/scientist-uses-stem-cells-to-repair-heart/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Will Intra-Osseous Injection of Umbilical Cord Blood Reduce Graft Failures?</title>
		<link>http://www.eprbiotechnews.com/2010/07/10/will-intra-osseous-injection-of-umbilical-cord-blood-reduce-graft-failures/</link>
		<comments>http://www.eprbiotechnews.com/2010/07/10/will-intra-osseous-injection-of-umbilical-cord-blood-reduce-graft-failures/#comments</comments>
		<pubDate>Sat, 10 Jul 2010 13:49:12 +0000</pubDate>
		<dc:creator>EPR Biotech News</dc:creator>
		
		<category><![CDATA[Biochemicals]]></category>

		<category><![CDATA[Biopharmaceutical]]></category>

		<category><![CDATA[Biotech]]></category>

		<category><![CDATA[Biotech Products]]></category>

		<category><![CDATA[Biotech Services]]></category>

		<category><![CDATA[Biotech Solutions]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Healthcare]]></category>

		<category><![CDATA[Medicine]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Science]]></category>

		<category><![CDATA[cord blood collections]]></category>

		<category><![CDATA[Cryo-Cell International]]></category>

		<category><![CDATA[Inc.]]></category>

		<category><![CDATA[stem cell transplant]]></category>

		<category><![CDATA[umbilical cord blood]]></category>

		<guid isPermaLink="false">http://www.eprbiotechnews.com/?p=80</guid>
		<description><![CDATA[
Researchers from Italy have reported that the injection of umbilical cord blood directly into the pelvic bones of patients with leukemia appears promising. These results were recently published in an early online publication of the Lancet Oncology on August 9, 2008.

Transplantation of bone marrow, peripheral blood stem cells, and umbilical cord blood is accomplished by intravenous infusion. The [...]]]></description>
		<wfw:commentRss>http://www.eprbiotechnews.com/2010/07/10/will-intra-osseous-injection-of-umbilical-cord-blood-reduce-graft-failures/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>

